FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bruno GIROS

Research Profile

Chemicals & Drugs

Living Beings

Co-author Network

Publications

TOP 3
Laurent Naudon; Fabiana Piscitelli; Vincenzo Di Marzo; Bruno GIROS; Valérie Daugé
Possible involvement of endocannabinoids in the increase of morphine consumption in maternally deprived rat.
Nicolas Narboux-Nême; Pothitos Pitychoutis; Bruno GIROS; Friederike Klempin; Valentina Mosienko; Natalia Alenina; Gaelle Angenard; Michael Bader; Evan Deneris; patricia Gaspar
Postnatal growth defects in mice with constitutive depletion of central serotonin.
Vincent Fournet; Bruno GIROS; Annie Andrieux; Gaetan de Lavilléon; Annie Schweitzer; Marie-Pascale Martres
Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bruno GIROS (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Laurent Naudon; Fabiana Piscitelli; Vincenzo Di Marzo; Bruno GIROS; Valérie Daugé
Possible involvement of endocannabinoids in the increase of morphine consumption in maternally deprived rat.
Neuropharmacology 2013;65():193-9.
2013: Nicolas Narboux-Nême; Pothitos Pitychoutis; Bruno GIROS; Friederike Klempin; Valentina Mosienko; Natalia Alenina; Gaelle Angenard; Michael Bader; Evan Deneris; patricia Gaspar
Postnatal growth defects in mice with constitutive depletion of central serotonin.
ACS chemical neuroscience 2013;4(1):171-81.
2012: Vincent Fournet; Bruno GIROS; Annie Andrieux; Gaetan de Lavilléon; Annie Schweitzer; Marie-Pascale Martres
Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice.
Journal of neurochemistry 2012;123(6):982-96.
2012: Aurélie Baudin; Kévin Blot; Valérie Daugé; Lucie Estevez; Bruno GIROS; Pierre Gressens; Satoru Otani; Julie Santamaria; Catherine Verney; Laurent Naudon
Maternal deprivation induces deficits in temporal memory and cognitive flexibility and exaggerates synaptic plasticity in the rat medial prefrontal cortex.
Neurobiology of learning and memory 2012;98(3):207-14.
2012: Britta Haenisch; Lidia Thiemer; Hu Xin; Eva Drescher; Sophie Gautron; Bruno GIROS; Heinz Bönisch
Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3.
Naunyn-Schmiedeberg's archives of pharmacology 2012;385(10):1017-23.
2012: A Bacq; L Balasse; G Biala; C Chevarin; A M Gardier; Bruno GIROS; B Guiard; M Hamon; F Louis; M-P Martres; A Schinkel; Vincent Vialou; Sophie Gautron
Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.
Molecular psychiatry 2012;17(9):926-39.
2012: Marie-Anne El Khoury; Bruno GIROS; Victor Gorgievski; Larissa Moutsimilli; Eleni T Tzavara
Interactions between the cannabinoid and dopaminergic systems: evidence from animal studies.
Progress in neuro-psychopharmacology & biological psychiatry 2012;38(1):36-50.
2012: Vincent Fournet; Bruno GIROS; Michel Hamon; Annie Andrieux; Caroline Chevarin; Jean Christophe Deloulme; Annie Schweitzer; Marie-Pascale Martres
The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances.
Journal of neurochemistry 2012;121(1):99-114.
2012: Séverine Farley; Sylvie Dumas; Salah El Mestikawy; Bruno GIROS
Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801.
Neuropharmacology 2012;62(1):503-17.
2011: Nicolas Narboux-Nême; Corinne Sagné; Gaelle Angenard; Silvina L Diaz; Stephane Doly; patricia Gaspar; Bruno GIROS; Michel Hamon; Laurence Lanfumey; Cédric B P Martin; Marie-Pascale Martres; Raymond Mongeau
Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2011;36(12):2538-50.
2011: Giselle Charron; François Delalande; Evelyne Doudnikoff; Bruno GIROS; Yannick Goumon; Alexis Laux; Qin Li; Marika Nosten-Bertrand; Grégory Porras; Chuan Qin; Alain Van Dorsselaer; Anne Vital; Pedro Barroso-Chinea; Amandine Berthet; Marie-Hélène Canron; Erwan Bezard
Endogenous morphine-like compound immunoreactivity increases in parkinsonism.
Brain : a journal of neurology 2011;134(Pt 8):2321-38.
2011: Vanessa Mourlon; Laurent Naudon; Bruno GIROS; Michèle Crumeyrolle-Arias; Valérie Daugé
Early stress leads to effects on estrous cycle and differential responses to stress.
Physiology & behavior 2011;102(3-4):304-10.
2010: Vincent Fournet; Marion Jany; Véronique Fabre; Farah Chali; Didier Orsal; Annie Schweitzer; Annie Andrieux; Fany Messanvi; Bruno GIROS; Michel Hamon; Laurence Lanfumey; Jean Christophe Deloulme; Marie-Pascale Martres
The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network.
Journal of neurochemistry 2010;115(6):1579-94.
2010: Vanessa Mourlon; Aurélie Baudin; Orianne Blanc; Andrea Lauber; Bruno GIROS; Laurent Naudon; Valérie Daugé
Maternal deprivation induces depressive-like behaviours only in female rats.
Behavioural brain research 2010;213(2):278-87.
2010: Coralie Fassier; James A Hutt; Steffen Scholpp; Andrew Lumsden; Bruno GIROS; Fatiha Nothias; Sylvie Schneider-Maunoury; Corinne Houart; Jamilé Hazan
Zebrafish atlastin controls motility and spinal motor axon architecture via inhibition of the BMP pathway.
Nature neuroscience 2010;13(11):1380-7.
2010: Severine Farley; Kalliopi Apazoglou; Jeffrey M Witkin; Bruno GIROS; Eleni T Tzavara
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2010;13(9):1207-18.
2010: Nicolas Pietrancosta; Albane Kessler; Franck-Cyril Favre-Besse; Nicolas Triballeau; Thomas Quentin; Bruno GIROS; Salah El Mestikawy; Francine Acher
Rose Bengal analogs and vesicular glutamate transporters (VGLUTs).
Bioorganic & medicinal chemistry 2010;18(18):6922-33.
2010: Anne Amphoux; Mark J Millan; Alex Cordi; Heinz Bönisch; Vincent Vialou; Clotilde Mannoury La Cour; Delphine S Dupuis; Bruno GIROS; Sophie Gautron
Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1- and alpha 2-adrenoceptor subtypes.
European journal of pharmacology 2010;634(1-3):1-9.
2010: Bénédicte Amilhon; Eve Lepicard; Thibault Renoir; Raymond Mongeau; Daniela Popa; Odile Poirel; Stéphanie Miot; Christelle Gras; Alain M Gardier; Jorge Gallego; Michel Hamon; Laurence Lanfumey; Bruno Gasnier; Bruno GIROS; Salah El Mestikawy
VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010;30(6):2198-210.
2010: Elise Morice; Cécile Denis; Bruno GIROS; Marika Nosten-Bertrand
Evidence of long-term expression of behavioral sensitization to both cocaine and ethanol in dopamine transporter knockout mice.
Psychopharmacology 2010;208(1):57-66.
2009: Lydie J Morel; Bruno GIROS; Valérie Daugé
Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(11):2469-76.
2008: Alireza Kashani; Eve Lepicard; Odile Poirel; Catherine Videau; Jean Philippe David; Catherine Fallet-Bianco; Axelle Simon; André Delacourte; Bruno GIROS; Jacques Epelbaum; Catalina Betancur; Salah El Mestikawy
Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease.
Neurobiology of aging 2008;29(11):1619-30.
2008: Jérôme Ruel; Sarah Emery; Régis Nouvian; Tiphaine Bersot; Bénédicte Amilhon; Jana M Van Rybroek; Guy Rebillard; Marc Lenoir; Michel Eybalin; Benjamin Delprat; Theru A Sivakumaran; Bruno GIROS; Salah El Mestikawy; Tobias Moser; Richard J H Smith; Marci M Lesperance; Jean-Luc Puel
Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice.
American journal of human genetics 2008;83(2):278-92.
2008: Vincent Vialou; Laure Balasse; Jacques Callebert; Jean-Marie Launay; Bruno GIROS; Sophie Gautron
Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice.
Journal of neurochemistry 2008;106(3):1471-82.
2008: Christelle Gras; Bénédicte Amilhon; Eve M Lepicard; Odile Poirel; Jacqueline Vinatier; Marc Herbin; Sylvie Dumas; Eleni T Tzavara; Mark R Wade; George Nomikos; Naïma Hanoun; Françoise Saurini; Marie-Louise Kemel; Bruno Gasnier; Bruno GIROS; Salah El Mestikawy
The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone.
Nature neuroscience 2008;11(3):292-300.
2008: Larissa Moutsimilli; Séverine Farley; Marie-Anne El Khoury; Christophe Chamot; Jean-Baptiste Sibarita; Victor Racine; Salah El Mestikawy; Flavie MATHIEU; Sylvie Dumas; Bruno GIROS; Eleni T Tzavara
Antipsychotics increase vesicular glutamate transporter 2 (VGLUT2) expression in thalamolimbic pathways.
Neuropharmacology 2008;54(3):497-508.
2008: Claire J Herzog; Stéphanie Miot; Isabelle M Mansuy; Bruno GIROS; Eleni T Tzavara
Chronic valproate normalizes behavior in mice overexpressing calcineurin.
European journal of pharmacology 2008;580(1-2):153-60.
2008: Caroline Bouvrais-Veret; stephanie weiss; Naïma Hanoun; Annie Andrieux; Annie Schweitzer; Didier Job; Michel Hamon; Bruno GIROS; Marie-Pascale Martres
Microtubule-associated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission.
Journal of neurochemistry 2008;104(3):745-56.
2008: Marika Nosten-Bertrand; Caroline Kappeler; Céline Dinocourt; Cécile Denis; Johanne Germain; Françoise Phan Dinh Tuy; Soraya Verstraeten; Chantal Alvarez; Christine Métin; Jamel Chelly; Bruno GIROS; Richard Miles; Antoine Depaulis; Fiona Francis
Epilepsy in Dcx knockout mice associated with discrete lamination defects and enhanced excitability in the hippocampus.
PloS one 2008;3(6):e2473.
2008: Flavie MATHIEU; Stéphanie Miot; Bruno Etain; Marie-Anne El Khoury; Fabien Chevalier; Frank Bellivier; Marion Leboyer; Bruno GIROS; Eleni T Tzavara
Association between the PPP3CC gene, coding for the calcineurin gamma catalytic subunit, and bipolar disorder.
Behavioral and brain functions : BBF 2008;4():2.
2007: stephanie weiss; Marika Nosten-Bertrand; J Michael McIntosh; Bruno GIROS; Marie-Pascale Martres
Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(12):2465-78.
2007: Elise Morice; Jean-Marie Billard; Cécile Denis; Flavie MATHIEU; Catalina Betancur; Jacques Epelbaum; Bruno GIROS; Marika Nosten-Bertrand
Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(10):2108-16.
2007: Vincent Vazquez; stephanie weiss; Bruno GIROS; Marie-Pascale Martres; Valérie Daugé
Maternal deprivation and handling modify the effect of the dopamine D3 receptor agonist, BP 897 on morphine-conditioned place preference in rats.
Psychopharmacology 2007;193(4):475-86.
2007: Malik Khelfaoui; Cécile Denis; Elly van Galen; Frédéric de Bock; Alain Schmitt; Christophe Houbron; Elise Morice; Bruno GIROS; Ger J A Ramakers; Laurent Fagni; Jamel Chelly; Marika Nosten-Bertrand; Pierre Billuart
Loss of X-linked mental retardation gene oligophrenin1 in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(35):9439-50.
2007: Caroline Bouvrais-Veret; stephanie weiss; Annie Andrieux; Annie Schweitzer; J Michael McIntosh; Didier Job; Bruno GIROS; Marie-Pascale Martres
Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice.
Neuropharmacology 2007;52(8):1691-700.
2007: stephanie weiss; Eleni T Tzavara; Richard J Davis; George Nomikos; J Michael McIntosh; Bruno GIROS; Marie-Pascale Martres
Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice.
Neuropharmacology 2007;52(7):1496-508.
2007: Alireza Kashani; Catalina Betancur; Bruno GIROS; Etienne Hirsch; Salah El Mestikawy
Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease.
Neurobiology of aging 2007;28(4):568-78.
2007: Claire Crozatier; Séverine Farley; I M Mansuy; Sylvie Dumas; Bruno GIROS; Eleni T Tzavara
Calcineurin (protein phosphatase 2B) is involved in the mechanisms of action of antidepressants.
Neuroscience 2007;144(4):1470-6.
2007: Vincent Vialou; L Balasse; Sylvie Dumas; Bruno GIROS; Sophie Gautron
Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain.
Neuroscience 2007;144(2):616-22.
2007: Franck Schürhoff; Andrei Szöke; Fabien Chevalier; Isabelle Roy; Alexandre Méary; Frank Bellivier; Bruno GIROS; Marion Leboyer
Schizotypal dimensions: an intermediate phenotype associated with the COMT high activity allele.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2007;144B(1):64-8.
2006: Vincent Vazquez; Bruno GIROS; Valérie Daugé
Maternal deprivation specifically enhances vulnerability to opiate dependence.
Behavioural pharmacology 2006;17(8):715-24.
2006: B Etain; Flavie MATHIEU; M Rietschel; W Maier; M Albus; P McKeon; S Roche; C Kealey; D Blackwood; W Muir; Frank Bellivier; C Henry; C Dina; S Gallina; H Gurling; A Malafosse; M Preisig; F Ferrero; S Cichon; J Schumacher; S Ohlraun; M Borrmann-Hassenbach; P Propping; Rami Abou Jamra; Thomas G. Schulze; A Marusic; Z M Dernovsek; Bruno GIROS; Thomas Bourgeron; A Lemainque; D Bacq; C Betard; C Charon; M M Nöthen; M Lathrop; M Leboyer
Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14.
Molecular psychiatry 2006;11(7):685-94.
2006: Vincent Vazquez; Jacqueline Penit-Soria; Claudette Durand; Marie-Jo Besson; Bruno GIROS; Valérie Daugé
Brief early handling increases morphine dependence in adult rats.
Behavioural brain research 2006;170(2):211-8.
2006: Anne Amphoux; Vincent Vialou; Eva Drescher; Michael Brüss; Clotilde Mannoury La Cour; Catherine Rochat; Mark J Millan; Bruno GIROS; Heinz Bönisch; Sophie Gautron
Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain.
Neuropharmacology 2006;50(8):941-52.
2006: Jacqueline Vinatier; Etienne Herzog; Marie-Aude Plamont; Sonja M Wojcik; Anne Schmidt; Nils Brose; Laurent Daviet; Salah El Mestikawy; Bruno GIROS
Interaction between the vesicular glutamate transporter type 1 and endophilin A1, a protein essential for endocytosis.
Journal of neurochemistry 2006;97(4):1111-25.
2006: Eleni T Tzavara; Dominic L Li; Larissa Moutsimilli; Tiziana Bisogno; Vincenzo Di Marzo; Lee A Phebus; George Nomikos; Bruno GIROS
Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.
Biological psychiatry 2006;59(6):508-15.
2005: Christelle Gras; Jacqueline Vinatier; Bénédicte Amilhon; Aline Guerci; Christo Christov; Philippe Ravassard; Bruno GIROS; Salah El Mestikawy
Developmentally regulated expression of VGLUT3 during early post-natal life.
Neuropharmacology 2005;49(6):901-11.
2005: Larissa Moutsimilli; Séverine Farley; Sylvie Dumas; Salah El Mestikawy; Bruno GIROS; Eleni T Tzavara
Selective cortical VGLUT1 increase as a marker for antidepressant activity.
Neuropharmacology 2005;49(6):890-900.
2005: Vincent Vazquez; Séverine Farley; Bruno GIROS; Valérie Daugé
Maternal deprivation increases behavioural reactivity to stressful situations in adulthood: suppression by the CCK2 antagonist L365,260.
Psychopharmacology 2005;181(4):706-13.
2005: Grazyna Biala; Catalina Betancur; Isabelle M Mansuy; Bruno GIROS
The reinforcing effects of chronic D-amphetamine and morphine are impaired in a line of memory-deficient mice overexpressing calcineurin.
The European journal of neuroscience 2005;21(11):3089-96.
2005: Vincent Vazquez; Jacqueline Penit-Soria; Claudette Durand; Marie-Jo Besson; Bruno GIROS; Valérie Daugé
Maternal deprivation increases vulnerability to morphine dependence and disturbs the enkephalinergic system in adulthood.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(18):4453-62.
2005: Rejean Guerriero; Anjali Rajadhyaksha; Claire Crozatier; Bruno GIROS; Marika Nosten-Bertrand; Barry E Kosofsky
Augmented constitutive CREB expression in the nucleus accumbens and striatum may contribute to the altered behavioral response to cocaine of adult mice exposed to cocaine in utero.
Developmental neuroscience 2005;27(2-4):235-48.
2005: Elise Morice; Cécile Denis; Alessandro Macario; Bruno GIROS; Marika Nosten-Bertrand
Constitutive hyperdopaminergia is functionally associated with reduced behavioral lateralization.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(3):575-81.
2004: Etienne Herzog; Marc Landry; Emmanuelle Buhler; Rabia Bouali-Benazzouz; C Legay; Christopher E Henderson; Frédéric Nagy; P Dreyfus; Bruno GIROS; Salah El Mestikawy
Expression of vesicular glutamate transporters, VGLUT1 and VGLUT2, in cholinergic spinal motoneurons.
The European journal of neuroscience 2004;20(7):1752-60.
2004: Elise Morice; Cécile Denis; Bruno GIROS; Marika Nosten-Bertrand
Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background.
The European journal of neuroscience 2004;20(1):120-6.
2004: Vincent Vialou; Anne Amphoux; Ronald Zwart; Bruno GIROS; Sophie Gautron
Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(11):2846-51.
2004: Etienne Herzog; J Gilchrist; Christelle Gras; Aude Muzerelle; Philippe Ravassard; Bruno GIROS; patricia Gaspar; Salah El Mestikawy
Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain.
Neuroscience 2004;123(4):983-1002.
2004: Christine Roubert; C Spielewoy; Philippe Soubrié; M Hamon; Bruno GIROS; Catalina Betancur
Altered neurotensin mrna expression in mice lacking the dopamine transporter.
Neuroscience 2004;123(2):537-46.
2003: Claire Crozatier; Rejean Guerriero; Flavie MATHIEU; Bruno GIROS; Marika Nosten-Bertrand; Barry E Kosofsky
Altered cocaine-induced behavioral sensitization in adult mice exposed to cocaine in utero.
Brain research. Developmental brain research 2003;147(1-2):97-105.
2003: Stéphane Jamain; Catalina Betancur; Bruno GIROS; Marion Leboyer; Thomas Bourgeron
[Genetics of autism: from genome scans to candidate genes].
Médecine sciences : M/S 2003;19(11):1081-90.
2003: Cendra Agulhon; Philippe Rostaing; Philippe Ravassard; Corinne Sagné; Antoine Triller; Bruno GIROS
Lysosomal amino acid transporter LYAAT-1 in the rat central nervous system: an in situ hybridization and immunohistochemical study.
The Journal of comparative neurology 2003;462(1):71-89.
2003: Stéphane Jamain; Hélène Quach; Catalina Betancur; Maria Råstam; Catherine Colineaux; I Carina Gillberg; Henrik Soderstrom; Bruno GIROS; Marion Leboyer; Christopher Gillberg; Thomas Bourgeron
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.
Nature genetics 2003;34(1):27-9.
2003: Thomas Bourgeron; Bruno GIROS
Genetic markers in psychiatric genetics.
Methods in molecular medicine 2003;77():63-98.
2002: Christelle Gras; Etienne Herzog; Gian Carlo Bellenchi; Véronique Bernard; Philippe Ravassard; Michel Pohl; Bruno Gasnier; Bruno GIROS; Salah El Mestikawy
A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(13):5442-51.
2002: Stéphane Jamain; Catalina Betancur; Hélène Quach; Anne Philippe; Marc Fellous; Bruno GIROS; Christopher Gillberg; Marion Leboyer; Thomas Bourgeron
Linkage and association of the glutamate receptor 6 gene with autism.
Molecular psychiatry 2002;7(3):302-10.
2002: Catalina Betancur; M Corbex; C Spielewoy; Anne Philippe; Jean-Louis Laplanche; Jean-Marie Launay; Christopher Gillberg; Marie-Christine Mouren-Siméoni; M Hamon; Bruno GIROS; Marika Nosten-Bertrand; Marion Leboyer
Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder.
Molecular psychiatry 2002;7(1):67-71.
2001: C Spielewoy; Grazyna Biala; Christine Roubert; M Hamon; Catalina Betancur; Bruno GIROS
Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter.
Psychopharmacology 2001;159(1):2-9.
2001: Howard H Gu; Xiaohong Wu; Bruno GIROS; Marc G Caron; Michael J Caplan; Gary Rudnick
The NH(2)-terminus of norepinephrine transporter contains a basolateral localization signal for epithelial cells.
Molecular biology of the cell 2001;12(12):3797-807.
2001: Etienne Herzog; Gian Carlo Bellenchi; Christelle Gras; Véronique Bernard; Philippe Ravassard; Cécile Bedet; Bruno Gasnier; Bruno GIROS; Salah El Mestikawy
The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(22):RC181.
2001: Christine Roubert; Corinne Sagné; Marika Kapsimali; Philippe Vernier; Franck Bourrat; Bruno GIROS
A Na(+)/Cl(-)-dependent transporter for catecholamines, identified as a norepinephrine transporter, is expressed in the brain of the teleost fish medaka (Oryzias latipes).
Molecular pharmacology 2001;60(3):462-73.
2001: Corinne Sagné; Cendra Agulhon; Philippe Ravassard; M Darmon; Michel Hamon; Salah El Mestikawy; Bruno Gasnier; Bruno GIROS
Identification and characterization of a lysosomal transporter for small neutral amino acids.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(13):7206-11.
2001: M Syringas; François Janin; Bruno GIROS; Jean Costentin; Jean-Jacques Bonnet
Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.
British journal of pharmacology 2001;133(3):387-94.
2001: Ezio Carboni; C Spielewoy; Cinzia Vacca; Marika Nosten-Bertrand; Bruno GIROS; GAETANO DI CHIARA
Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(9):RC141: 1-4.
2001: Christine Roubert; P J Cox; M Bruss; M Hamon; Heinz Bönisch; Bruno GIROS
Determination of residues in the norepinephrine transporter that are critical for tricyclic antidepressant affinity.
The Journal of biological chemistry 2001;276(11):8254-60.
2000: M Syringas; François Janin; S Mezghanni; Bruno GIROS; Jean Costentin; Jean-Jacques Bonnet
Structural domains of chimeric dopamine-noradrenaline human transporters involved in the Na(+)- and Cl(-)-dependence of dopamine transport.
Molecular pharmacology 2000;58(6):1404-11.
2000: Kuei Tseng; Christine Roubert; L Do; Marcelo Rubinstein; M A Kelly; David K Grandy; Malcolm J Low; Oscar S Gershanik; M Gustavo Murer; Bruno GIROS; Rita Raisman-Vozari
Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient mice.
Brain research. Molecular brain research 2000;80(1):1-6.
2000: C Spielewoy; Christine Roubert; M Hamon; Marika Nosten-Bertrand; Catalina Betancur; Bruno GIROS
Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice.
Behavioural pharmacology 2000;11(3-4):279-90.
2000: C Spielewoy; François Gonon; Christine Roubert; V Fauchey; Ghassan Jaber; Marc G Caron; B P Roques; M Hamon; Catalina Betancur; R Maldonado; Bruno GIROS
Increased rewarding properties of morphine in dopamine-transporter knockout mice.
The European journal of neuroscience 2000;12(5):1827-37.
2000: Brigitte Dumartin; Ghassan Jaber; François Gonon; Marc G Caron; Bruno GIROS; Bertrand Bloch
Dopamine tone regulates D1 receptor trafficking and delivery in striatal neurons in dopamine transporter-deficient mice.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(4):1879-84.
2000: Justine Masson; patricia Gaspar; Z Aïdouni; Pascal Ezan; Bruno GIROS; Michel Hamon; Salah El Mestikawy
Ontogeny of Rxt1, a vesicular "orphan" Na(+)/Cl(-)-dependent transporter, in the rat.
Neuroscience 2000;96(3):627-37.
1999: Heinz Bönisch; Fabian Runkel; Christine Roubert; Bruno GIROS; Michael Brüss
The human desipramine-sensitive noradrenaline transporter and the importance of defined amino acids for its function.
Journal of autonomic pharmacology 1999;19(6):327-33.
1999: Ghassan Jaber; Brigitte Dumartin; Corinne Sagné; J W Haycock; Christine Roubert; Bruno GIROS; Bertrand Bloch; Marc G Caron
Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter.
The European journal of neuroscience 1999;11(10):3499-511.
1999: Justine Masson; P Cervera; S Côté; J Morisette; Z Aïdouni; Bruno GIROS; Michel Hamon; P Falardeau; S E Mestikawy
Characterization and distribution of Hxt1, a Na(+)/Cl(-)-dependent orphan transporter, in the human brain.
Journal of neuroscience research 1999;56(2):146-59.
1999: Justine Masson; Mustapha Riad; F Chaudhry; M Darmon; Z Aïdouni; Marie Conrath; Bruno GIROS; Michel Hamon; J Storm-Mathisen; Laurent Descarries; Salah El Mestikawy
Unexpected localization of the Na+/Cl--dependent-like orphan transporter, Rxt1, on synaptic vesicles in the rat central nervous system.
The European journal of neuroscience 1999;11(4):1349-61.
1998: Marie-Pascale Martres; B Demeneix; Naïma Hanoun; Michel Hamon; Bruno GIROS
Up- and down-expression of the dopamine transporter by plasmid DNA transfer in the rat brain.
The European journal of neuroscience 1998;10(12):3607-16.
1998: Olivier Cases; Cecile Lebrand; Bruno GIROS; Tania Vitalis; Edward De Maeyer; Marc G Caron; David J Price; patricia Gaspar; Isabelle Seif
Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(17):6914-27.
1998: Howard A Rockman; DJ Choi; S A Akhter; M Jaber; Bruno GIROS; Robert J Lefkowitz; Marc G Caron; Walter J Koch
Control of myocardial contractile function by the level of beta-adrenergic receptor kinase 1 in gene-targeted mice.
The Journal of biological chemistry 1998;273(29):18180-4.
1998: Beatriz A Rocha; F Fumagalli; Raul R Gainetdinov; Sara R Jones; Robert Ator; Bruno GIROS; Gary Miller; Marc G Caron
Cocaine self-administration in dopamine-transporter knockout mice.
Nature neuroscience 1998;1(2):132-7.
1998: Sara R Jones; Raul R Gainetdinov; M Jaber; Bruno GIROS; R Mark Wightman; Marc G Caron
Profound neuronal plasticity in response to inactivation of the dopamine transporter.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(7):4029-34.
1998: M Jaber; Bertrand Bloch; Marc G Caron; Bruno GIROS
[Behavioral, cellular and molecular consequences of the dopamine transporter gene inactivation].
Comptes rendus des séances de la Société de biologie et de ses filiales 1998;192(6):1127-37.
1998: S R Nash; Bruno GIROS; Stephen Kingsmore; K M Kim; Salah El Mestikawy; Q Dong; F Fumagalli; Michael F Seldin; Marc G Caron
Cloning, gene structure and genomic localization of an orphan transporter from mouse kidney with six alternatively-spliced isoforms.
Receptors & channels 1998;6(2):113-28.
1998: F Fumagalli; S Jones; R Bossé; M Jaber; Bruno GIROS; C Missale; R Mark Wightman; Marc G Caron
Inactivation of the dopamine transporter reveals essential roles of dopamine in the control of locomotion, psychostimulant response, and pituitary function.
Advances in pharmacology (San Diego, Calif.) 1998;42():179-82.
1997: Corinne Sagné; Salah El Mestikawy; MF Isambert; Michel Hamon; Jean-Pierre Henry; Bruno GIROS; Bruno Gasnier
Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases.
FEBS letters 1997;417(2):177-83.
1997: M Jaber; S Jones; Bruno GIROS; Marc G Caron
The dopamine transporter: a crucial component regulating dopamine transmission.
Movement disorders : official journal of the Movement Disorder Society 1997;12(5):629-33.
1997: R Bossé; F Fumagalli; M Jaber; Bruno GIROS; Raul R Gainetdinov; William C Wetsel; C Missale; Marc G Caron
Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter.
Neuron 1997;19(1):127-38.
1997: Incarnation Aubert; Corinne Brana; christian pellevoisin; Bruno GIROS; I Caille; Dominique Carles; C Vital; Bertrand Bloch
Molecular anatomy of the development of the human substantia nigra.
The Journal of comparative neurology 1997;379(1):72-87.
1997: Jian Zhang; Stephen S G Ferguson; Larry S Barak; M J Aber; Bruno GIROS; Robert J Lefkowitz; Marc G Caron
Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arrestins in receptor desensitization and resensitization.
Receptors & channels 1997;5(3-4):193-9.
1996: Ghassan Jaber; Walter J Koch; Howard A Rockman; Bradley R Smith; Richard A Bond; Kathleen K Sulik; J Ross; R J Lefkowitz; Marc G Caron; Bruno GIROS
Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(23):12974-9.
1996: Christian Pifl; Oleh Hornykiewicz; Bruno GIROS; Marc G Caron
Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter.
The Journal of pharmacology and experimental therapeutics 1996;277(3):1437-43.
1996: Bruno GIROS; M Jaber; Sara R Jones; R Mark Wightman; Marc G Caron
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.
Nature 1996;379(6566):606-12.
1996: Justine Masson; M Pohl; Z Aïdouni; Bruno GIROS; Michel Hamon; Salah El Mestikawy
The two orphan Na+/Cl(-)-dependent transporters Rxt1 and V-7-3-2 have an overlapping expression pattern in the rat central nervous system.
Receptors & channels 1996;4(4):227-42.
1996: Christian Pifl; Bruno GIROS; Marc G Caron
The dopamine transporter. The cloned target site of parkinsonism-inducing toxins and of drugs of abuse.
Advances in neurology 1996;69():235-8.
1995: Justine Masson; X Langlois; Laurence Lanfumey; C Gérard; Z Aïdouni; Bruno GIROS; Michel Hamon; Salah El Mestikawy
Immunolabeling of the Na+/Cl(-)-dependent "orphan" transporter Rxt1 in the rat central nervous system.
Journal of neuroscience research 1995;42(3):423-32.
1995: Bruno GIROS; M Pohl; J M Rochelle; Michael F Seldin
Chromosomal localization of opioid peptide and receptor genes in the mouse.
Life sciences 1995;56(18):PL369-75.
1994: Bruno GIROS; Yanming Wang; S Suter; S B McLeskey; Christian Pifl; Marc G Caron
Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters.
The Journal of biological chemistry 1994;269(23):15985-8.
1994: Stephen Kingsmore; Bruno GIROS; D Suh; M Bieniarz; Marc G Caron; Michael F Seldin
Glycine receptor beta-subunit gene mutation in spastic mouse associated with LINE-1 element insertion.
Nature genetics 1994;7(2):136-41.
1994: K M Kim; Stephen Kingsmore; H Han; T L Yang-Feng; N Godinot; Michael F Seldin; Marc G Caron; Bruno GIROS
Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes.
Molecular pharmacology 1994;45(4):608-17.
1994: T Li; L Yang; C Wiese; C T Xu; Z Zeng; Bruno GIROS; Marc G Caron; H W Moises; X Liu
No association between alleles or genotypes at the dopamine transporter gene and schizophrenia.
Psychiatry research 1994;52(1):17-23.
1994: F L Zhang; Ronald E Diehl; Nancy E Kohl; Jackson B Gibbs; Bruno GIROS; Patrick J Casey; CA Omer
cDNA cloning and expression of rat and human protein geranylgeranyltransferase type-I.
The Journal of biological chemistry 1994;269(5):3175-80.
1994: Salah El Mestikawy; Bruno GIROS; M Pohl; M Hamon; Stephen Kingsmore; Michael F Seldin; Marc G Caron
Characterization of an atypical member of the Na+/Cl(-)-dependent transporter family: chromosomal localization and distribution in GABAergic and glutamatergic neurons in the rat brain.
Journal of neurochemistry 1994;62(2):445-55.
1994: S R Nash; Bruno GIROS; Stephen Kingsmore; J M Rochelle; S T Suter; P Gregor; Michael F Seldin; Marc G Caron
Cloning, pharmacological characterization, and genomic localization of the human creatine transporter.
Receptors & channels 1994;2(2):165-74.
1994: O Sabaté; Dominique Campion; Thierry d'Amato; M P Martres; Pierre Sokoloff; Bruno GIROS; Marion Leboyer; M Jay; F Guedj; Florence Thibaut
Failure to find evidence for linkage or association between the dopamine D3 receptor gene and schizophrenia.
The American journal of psychiatry 1994;151(1):107-11.
1993: Christian Pifl; Bruno GIROS; Marc G Caron
Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1993;13(10):4246-53.
1993: William Byerley; Hilary Coon; M Hoff; J Holik; Merilyne C Waldo; Robert Freedman; Marc G Caron; Bruno GIROS
Human dopamine transporter gene not linked to schizophrenia in multigenerational pedigrees.
Human heredity 1993;43(5):319-22.
1993: William Byerley; M Hoff; J Holik; Marc G Caron; Bruno GIROS
VNTR polymorphism for the human dopamine transporter gene (DAT1).
Human molecular genetics 1993;2(3):335.
1993: Bruno GIROS; Marc G Caron
Molecular characterization of the dopamine transporter.
Trends in pharmacological sciences 1993;14(2):43-9.
1993: Bruno GIROS; Pierre Sokoloff; M P Martres; Lars Lannfelt; M Andrieux; R Besançon; C Pilon; M L Bouthenet; Evelyne Souil; Jean-Charles Schwartz
The third dopamine receptor (D3): new perspectives in therapeutics.
Psychopharmacology series 1993;10():82-93.
1992: D Lévesque; Jorge Diaz; C Pilon; M P Martres; Bruno GIROS; Evelyne Souil; D Schott; J L Morgat; Jean-Charles Schwartz; Pierre Sokoloff
Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(17):8155-9.
1992: Bruno GIROS; Salah El Mestikawy; N Godinot; K Zheng; H Han; T Yang-Feng; Marc G Caron
Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.
Molecular pharmacology 1992;42(3):383-90.
1992: Pierre Sokoloff; M Andrieux; R Besançon; C Pilon; M P Martres; Bruno GIROS; Jean-Charles Schwartz
Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor.
European journal of pharmacology 1992;225(4):331-7.
1992: Pierre Sokoloff; M P Martres; Bruno GIROS; M L Bouthenet; Jean-Charles Schwartz
Heterogeneity and regulation of central dopamine receptor subtypes studied by cDNA cloning methodology.
Neurochemistry international 1992;20 Suppl():27S-32S.
1992: Pierre Sokoloff; M P Martres; Bruno GIROS; M L Bouthenet; Jean-Charles Schwartz
The third dopamine receptor (D3) as a novel target for antipsychotics.
Biochemical pharmacology 1992;43(4):659-66.
1992: Pierre Sokoloff; Bruno GIROS; M P Martres; M Andrieux; R Besancon; C Pilon; M L Bouthenet; Evelyne Souil; Jean-Charles Schwartz
Localization and function of the D3 dopamine receptor.
Arzneimittel-Forschung 1992;42(2A):224-30.
1992: M P Martres; Pierre Sokoloff; Bruno GIROS; M L Bouthenet; C Pilon; Lars Lannfelt; Jean-Charles Schwartz
[Dopaminergic receptors, multiple targets for neuroleptics].
Annales médico-psychologiques 1992;150(2-3):119-23.
1992: M P Martres; Pierre Sokoloff; Bruno GIROS; Jean-Charles Schwartz
Effects of dopaminergic transmission interruption on the D2 receptor isoforms in various cerebral tissues.
Journal of neurochemistry 1992;58(2):673-9.
1991: Bruno GIROS; Salah El Mestikawy; L Bertrand; Marc G Caron
Cloning and functional characterization of a cocaine-sensitive dopamine transporter.
FEBS letters 1991;295(1-3):149-54.
1991: M L Bouthenet; Evelyne Souil; M P Martres; Pierre Sokoloff; Bruno GIROS; Jean-Charles Schwartz
Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA.
Brain research 1991;564(2):203-19.
1991: Daniele Piomelli; C Pilon; Bruno GIROS; Pierre Sokoloff; M P Martres; Jean-Charles Schwartz
Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism.
Nature 1991;353(6340):164-7.
1991: MB Le Coniat; Pierre Sokoloff; J Hillion; M P Martres; Bruno GIROS; C Pilon; J C Schwartz; R Berger
Chromosomal localization of the human D3 dopamine receptor gene.
Human genetics 1991;87(5):618-20.
1991: Bruno GIROS; M P Martres; C Pilon; Pierre Sokoloff; J C Schwartz
Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing.
Biochemical and biophysical research communications 1991;176(3):1584-92.
1991: Bruno GIROS
[Third dopamine receptor. A new target of action of neuroleptics].
Pathologie-biologie 1991;39(4):252-4.
1990: C Llorens-Cortes; Bruno GIROS; Jean-Charles Schwartz
A novel potential metallopeptidase derived from the enkephalinase gene by alternative splicing.
Journal of neurochemistry 1990;55(6):2146-8.
1990: Pierre Sokoloff; Bruno GIROS; M P Martres; M L Bouthenet; Jean-Charles Schwartz
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.
Nature 1990;347(6289):146-51.
1990: Catherine Llorens-Cortes; J G Van Amsterdam; Bruno GIROS; T T Quach; Jean-Charles Schwartz
Enkephalin biosynthesis and release in mouse striatum are inhibited by GABA receptor stimulation: compared changes in preproenkephalin mRNA and Tyr-Gly-Gly levels.
Brain research. Molecular brain research 1990;8(3):227-33.
1990: Catherine Llorens-Cortes; Bruno GIROS; T T Quach; Jean-Charles Schwartz
Adaptative changes in two indices of enkephalin neuron activity in mouse striatum following GABAergic stimulation.
Progress in clinical and biological research 1990;328():203-6.
1990: Bruno GIROS; M P Martres; Pierre Sokoloff; J C Schwartz
[Gene cloning of human dopaminergic D3 receptor and identification of its chromosome].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1990;311(13):501-8.
1989: Bruno GIROS; Pierre Sokoloff; M P Martres; J F Riou; L J Emorine; Jean-Charles Schwartz
Alternative splicing directs the expression of two D2 dopamine receptor isoforms.
Nature 1989;342(6252):923-6.
1989: B Malfroy; H Kado-Fong; C Gros; Bruno GIROS; J C Schwartz; R Hellmiss
Molecular cloning and amino acid sequence of rat kidney aminopeptidase M: a member of a super family of zinc-metallohydrolases.
Biochemical and biophysical research communications 1989;161(1):236-41.
1989: Catherine Llorens-Cortes; M P Martres; Y Van Amsterdam; Bruno GIROS; C Gros; H Pollard; Jean-Charles Schwartz
[Dopamine and enkephalins. Effects of dopaminergic agents on the levels of striatal tyrosyl-glycyl-glycine].
L'Encéphale 1989;15 Spec No():105-9.
1988: C Gros; Bruno GIROS; Jean-Charles Schwartz; A Vlaiculescu; J Costentin; JM Lecomte
Potent inhibition of cerebral aminopeptidases by carbaphethiol, a parenterally active compound.
Neuropeptides 1988;12(3):111-8.
1987: A Michael-Titus; P Preterre; Bruno GIROS; Jean Costentin
Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor.
The Journal of pharmacology and experimental therapeutics 1987;243(3):1062-6.
1987: Bruno GIROS; C Gros; Jean-Charles Schwartz; D Danvy; J C Plaquevent; L Duhamel; P Duhamel; A Vlaiculescu; J Costentin; JM Lecomte
Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
The Journal of pharmacology and experimental therapeutics 1987;243(2):666-73.
1987: Bruno GIROS; J C Schwartz
[Opioid peptides and their receptors].
La Revue du praticien 1987;37(29):1695-8, 1701-2.
1987: Bruno GIROS; C Gros; C Llorens-Cortes; J C Schwartz
[Opioid peptides: metabolism and receptors].
Gastroentérologie clinique et biologique 1987;11(3 Pt 2):7B-13B.
1987: J C Schwartz; Bruno GIROS; C Gros; C Llorens-Cortes; J M Arrang; M Garbarg; H Pollard
Novel agents affecting enkephalinergic and histaminergic transmissions in brain.
Cephalalgia : an international journal of headache 1987;7 Suppl 6():32-5.
1986: Bruno GIROS; C Llorens-Cortes; C Gros; J C Schwartz
The endogenous tripeptide Tyr-Gly-Gly as a possible metabolite of opioid peptides in rat brain: identification, regional distribution, effects of lesions and formation in depolarized slices.
Peptides 1986;7(4):669-77.
1986: Bruno GIROS; C Gros; B Solhonne; Jean-Charles Schwartz
Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
Molecular pharmacology 1986;29(3):281-7.
1986: Jean-Charles Schwartz; S de la Baume; M L Bouthenet; Bruno GIROS; C Gros; C Llorens-Cortes; H Pollard; N Sales; B Solhonne; J Costentin
[Neuropeptidases responsible for the inactivation of enkephalins and the pharmacology of their inhibitors].
Journal de pharmacologie 1986;17 Suppl 2():104-22.
1986: Bruno GIROS; C Llorens-Cortes; C Gros; J C Schwartz
The endogenous tripeptide Tyr-Gly-Gly as an extracellular metabolite of enkephalins in rat brain: origin and metabolism.
NIDA research monograph 1986;75():271-4.
1986: C Gros; B Solhonne; Bruno GIROS; H Pollard; N Salès; Jean-Charles Schwartz; P Ronco; P Verroust
Immunohistochemical and subcellular studies of aminopeptidase M localization in rat brain: microvessels and synaptic membranes.
NIDA research monograph 1986;75():303-6.
1985: C Gros; Bruno GIROS; J C Schwartz
Identification of aminopeptidase M as an enkephalin-inactivating enzyme in rat cerebral membranes.
Biochemistry 1985;24(9):2179-85.
1985: C Gros; Bruno GIROS; J C Schwartz
Purification of membrane-bound aminopeptidase from rat brain: identification of aminopeptidase M.
Neuropeptides 1985;5(4-6):485-8.
1985: C Gros; Bruno GIROS; C Llorens; B Malfroy; H Pollard; I Pachot; J C Schwartz; J C Mazie
Enkephalin metabolism and its inhibition.
Biochemical Society transactions 1985;13(1):47-50.
1983: Bruno GIROS; S de la Baume; C Gros; J C Schwartz
[Inhibition of the evoked liberation of (Met5)enkephalin from slices of globus pallidus in the presence of thiorphan and bestatin].
Comptes rendus des séances de l'Académie des sciences. Série III, Sciences de la vie 1983;297(13):609-12.